Week45, 2022
1. Influenza activity is elevated nationwide, with 14.7% of clinical specimens testing positive, primarily Influenza A (99.2%) and a minor presence of Influenza B (0.8%).
2. Influenza A(H3N2) is the dominant subtype accounting for 75.4% of subtyped Influenza A viruses in public health labs; A(H1N1)pdm09 comprises 24.6%.
3. The cumulative hospitalization rate of 8.1 per 100,000 is higher than week 45 rates in any prior season since 2010, with the highest rates in adults aged 65+ (18.6) and children aged 0-4 years (13.6).
4. Deaths attributed to pneumonia, influenza, or COVID-19 reached 9.4%, above the epidemic threshold, with influenza-related deaths slightly increasing but primarily overshadowed by COVID-19.
5. 5.8% of outpatient visits were due to influenza-like illness (ILI), surpassing the baseline of 2.5%, with high or very high activity reported in 30 jurisdictions.
6. Vaccination is recommended for individuals aged 6 months and older; the vaccine matches circulating strains well, and vaccination efforts are ongoing.
7. Two pediatric deaths were reported this week, bringing the seasonal total to seven.
8. Antigenic and genetic analyses show circulating viruses are similar to strains in the current vaccine.
9. Regional positivity rates for influenza are climbing in multiple locations, highlighting increasing viral activity.
10. Influenza A contributes 95.6% of hospitalizations, of which 76.7% are associated with the A(H3N2) subtype.